| Dr Nicole Lynn Schmidt, AUD | |
|
5333 Hollister Ave Ste 165, Santa Barbara, CA 93111-2461 | |
| (805) 967-4200 | |
| Not Available |
| Full Name | Dr Nicole Lynn Schmidt |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 5333 Hollister Ave Ste 165, Santa Barbara, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700429487 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 3482 (California) | Primary |
| 231H00000X | Audiologist | (* (Not Available)) | Secondary |
| Provider Name | Regents Of The University Of California - Ucsf |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1265890263 PECOS PAC ID: 3375822471 Enrollment ID: O20161114000177 |
News Archive
Concert Pharmaceuticals, Inc. announced today that it has initiated a Phase 1b clinical study with CTP-518, its investigational oral HIV protease inhibitor for the treatment of HIV infection. In connection with the start of this multiple ascending dose arm of the Phase 1 study, Concert will receive a $12 million milestone payment under the company's strategic alliance with GlaxoSmithKline.
Boston Medical Center has significantly reduced the amount of time that pediatric patients experiencing pain from sickle cell disease (SCD) wait before receiving pain medication when they come to the emergency department. The hospital's quality improvement initiative cut the wait time by more than 50 percent, from an average of 56 minutes to 23 minutes, from triage to administration of the first dose of pain medication.
An estimated 42 percent of Americans use herbal medicines or nutritional supplements. Many people taking these products and their physicians are unaware of the adverse reactions they can cause.
Trius Therapeutics, Inc. announced today that it has reached agreement with the United States Food and Drug Administration (FDA), under the Special Protocol Assessment (SPA) process, on the design of its planned Phase 3 study for the oral dosage form of torezolid phosphate for treatment of acute bacterial skin and skin structure infections (ABSSSI).
WHO reported there were 4 additional suspected cases. Three out of the four suspects were relatives of the 20-year-old nurse and the fourth suspect is a male patient who stayed in the same ward.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nicole Lynn Schmidt, AUD 450 Sutter St, Rm 1400, San Francisco, CA 94108-4003 Ph: (415) 362-2901 | Dr Nicole Lynn Schmidt, AUD 5333 Hollister Ave Ste 165, Santa Barbara, CA 93111-2461 Ph: (805) 967-4200 |
News Archive
Concert Pharmaceuticals, Inc. announced today that it has initiated a Phase 1b clinical study with CTP-518, its investigational oral HIV protease inhibitor for the treatment of HIV infection. In connection with the start of this multiple ascending dose arm of the Phase 1 study, Concert will receive a $12 million milestone payment under the company's strategic alliance with GlaxoSmithKline.
Boston Medical Center has significantly reduced the amount of time that pediatric patients experiencing pain from sickle cell disease (SCD) wait before receiving pain medication when they come to the emergency department. The hospital's quality improvement initiative cut the wait time by more than 50 percent, from an average of 56 minutes to 23 minutes, from triage to administration of the first dose of pain medication.
An estimated 42 percent of Americans use herbal medicines or nutritional supplements. Many people taking these products and their physicians are unaware of the adverse reactions they can cause.
Trius Therapeutics, Inc. announced today that it has reached agreement with the United States Food and Drug Administration (FDA), under the Special Protocol Assessment (SPA) process, on the design of its planned Phase 3 study for the oral dosage form of torezolid phosphate for treatment of acute bacterial skin and skin structure infections (ABSSSI).
WHO reported there were 4 additional suspected cases. Three out of the four suspects were relatives of the 20-year-old nurse and the fourth suspect is a male patient who stayed in the same ward.
› Verified 1 days ago
Dr. Ira J Nadell, PH.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 215 W Pueblo St, Santa Barbara, CA 93105 Phone: 805-563-1134 Fax: 805-563-8388 | |
Dodero Hearing Center Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1801 State St, #a, Santa Barbara, CA 93101 Phone: 805-687-4508 Fax: 805-687-5879 | |
Legacy Audiology, Inc. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 5360 Hollister Ave Ste 1, Santa Barbara, CA 93111 Phone: 805-696-6811 Fax: 805-696-6453 | |
Hearing Consultants Of California Audiologist Medicare: Not Enrolled in Medicare Practice Location: 5360 Hollister Ave #1, Santa Barbara, CA 93111 Phone: 805-696-6811 Fax: 805-696-6453 | |
Charles Henry Hunt Iii, Audiologist Medicare: Accepting Medicare Assignments Practice Location: 4151 Foothill Rd, Santa Barbara, CA 93110 Phone: 805-681-7636 | |
Aubree Janelle Newman, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 5360 Hollister Ave Ste 1, Santa Barbara, CA 93111 Phone: 805-696-6811 Fax: 805-696-6453 |